Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor
about
Myeloid-derived suppressor cells: linking inflammation and cancerThe role of NKT cells in tumor immunityPaving the Road to Tumor Development and Spreading: Myeloid-Derived Suppressor Cells are Ruling the FateMyeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implicationsThe CXCL8-CXCR1/2 pathways in cancerPhenotype, development, and biological function of myeloid-derived suppressor cellsPhosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell functionDynamic change and impact of myeloid-derived suppressor cells in allogeneic bone marrow transplantation in miceEffect of the premalignant and tumor microenvironment on immune cell cytokine production in head and neck cancer.Dendritic cell recovery post-lymphodepletion: a potential mechanism for anti-cancer adoptive T cell therapy and vaccinationA population of HLA-DR+ immature cells accumulates in the blood dendritic cell compartment of patients with different types of cancer.HLA-DR+ immature cells exhibit reduced antigen-presenting cell function but respond to CD40 stimulationTumor-induced myeloid dysfunction and its implications for cancer immunotherapyLower peripheral blood CD14+ monocyte frequency and higher CD34+ progenitor cell frequency are associated with HBV vaccine induced response in HIV infected individuals.Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells.Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinomaGr-1+ CD11b+ myeloid-derived suppressor cells suppress inflammation and promote insulin sensitivity in obesity.Complexity and challenges in defining myeloid-derived suppressor cellsImmunosuppressive tumor microenvironment in cervical cancer patientsThe Role and Potential Therapeutic Application of Myeloid-Derived Suppressor Cells in Allo- and AutoimmunityMicroRNA-200c Promotes Suppressive Potential of Myeloid-Derived Suppressor Cells by Modulating PTEN and FOG2 Expression.1alpha,25-Dihydroxyvitamin D(3) to skew intratumoral levels of immune inhibitory CD34(+) progenitor cells into dendritic cells.Role of Myeloid-Derived Suppressor Cells in Glucocorticoid-Mediated Amelioration of FSGS.Immunology and Immunotherapy of Head and Neck CancerCD38-Expressing Myeloid-Derived Suppressor Cells Promote Tumor Growth in a Murine Model of Esophageal Cancer.Myeloid derived suppressor cells in human diseasesAnti-Gr-1 antibody depletion fails to eliminate hepatic myeloid-derived suppressor cells in tumor-bearing mice.Defective differentiation of myeloid and plasmacytoid dendritic cells in advanced cancer patients is not normalized by tyrosine kinase inhibition of the vascular endothelial growth factor receptor.Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells.Protumor activities of the immune response: insights in the mechanisms of immunological shift, oncotraining, and oncopromotion.STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients.Changing the paradigm: the potential for targeted therapy in laryngeal squamous cell carcinoma.Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cellsThe tumor microenvironment and its role in promoting tumor growth.Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity.Overcoming barriers to effective immunotherapy: MDSCs, TAMs, and Tregs as mediators of the immunosuppressive microenvironment in head and neck cancer.p21 suppresses inflammation and tumorigenesis on pRB-deficient stratified epithelia.Molecular mechanisms of head and neck cancer.Immune Suppression Mediated by Myeloid and Lymphoid Derived Immune Cells in the Tumor Microenvironment Facilitates Progression of Thyroid Cancers Driven by HrasG12V and Pten Loss.HIF-α/MIF and NF-κB/IL-6 axes contribute to the recruitment of CD11b+Gr-1+ myeloid cells in hypoxic microenvironment of HNSCC.
P2860
Q24641811-50A6EAEC-C1DE-4DE5-8547-80131B9D3053Q24648939-465A1BF9-DE7D-4B98-89CA-7754C71CDD76Q26777205-932C99CE-EBD8-4240-B40A-ECCCADA64553Q27014189-5BCFFE1C-AA08-4370-99B5-5D14AFD42992Q28075994-5EC85A73-3ADE-4369-86BB-31F5F9B43172Q28079046-F5F3F4AE-A0BD-478A-B4EC-7F2C0B786625Q28510096-4CAEBEEF-2BC8-4BBD-8D5E-DE64C8EB909AQ33573652-EFFF3146-C479-41D3-9DD9-E4840BA9ECD7Q33820247-74A34B1B-E5DE-4A16-98DC-E6B88DBF81E1Q34759603-C0723374-D9CE-4E3D-9648-869AFDDC383BQ34768502-92CDF7FB-FFF7-41C4-BEF9-40EE75E08430Q34768526-85428F5A-6B83-4C5D-84AE-47533D00153CQ34810257-A098C6B1-71E2-4345-A157-84E2E4B4370FQ34850890-F511237E-5EDF-452F-9276-C63428A82C50Q35052425-77D8AABF-DDB9-41A9-BC33-23BA70A9051AQ35067627-769E7CA9-8FE8-48C7-8E2C-30F4F079D4EDQ35067909-B24FC4E6-0705-4627-8F86-6DB701F59450Q35509317-28E8B547-8F2A-4131-AD2F-68225F4617E5Q35603131-1AF5983F-F4A3-4BA0-9D11-4B814711D7F8Q35675017-13CC22FC-FA01-428F-950E-82B5AE7DA0A1Q35748965-A4EEFFFC-95F8-4F41-A22C-B129B7630630Q35915769-FAAD51E2-CEDA-4626-AF6A-AF15A9A31C9EQ36003095-590457C3-FBCE-4A13-BAEE-384291C3565CQ36100837-E3A8E5A5-1268-4D5F-9034-843CDC8A67F6Q36118086-B7647AEE-33E3-4C14-A428-C7F3A83D3B34Q36338349-06360E8F-1D16-4631-B0C3-408285343A3DQ36410807-5F255854-16B1-42E7-9502-53EB4BF0AD3EQ36464882-3D24213F-C038-4125-BDB5-F706D8813180Q36489379-0DFFF169-6103-4313-94BE-C24AC95D62D2Q36729107-02984B40-973F-4464-A6A8-E0454A583D46Q36733391-6FE13210-2B20-4603-859F-F595ABB3A436Q36849676-48C64D18-94E0-42E6-A077-C43068BA6379Q36916400-CCB99FAE-331F-4F9B-9196-521620340389Q36946019-56257FCB-0BF9-4F0F-AA52-B5D6B4995D4FQ36996588-FDDE25C1-816F-4C15-BFFB-2E68BA211F56Q37017190-A4AA9FE5-7139-429D-A2CE-D72EFEE826FFQ37021095-9001865B-5700-4AB7-A221-F8EEF16A411CQ37159537-73FB17E2-CAE5-4A81-A2B6-2D291A25D4FBQ37486166-29F761CB-85A5-421E-A1DD-C3830587CCE3Q37689607-F428CD42-4280-442C-9108-8816974F2C78
P2860
Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Mechanisms of immune suppressi ...... hage colony-stimulating factor
@ast
Mechanisms of immune suppressi ...... hage colony-stimulating factor
@en
Mechanisms of immune suppressi ...... hage colony-stimulating factor
@en-gb
Mechanisms of immune suppressi ...... hage colony-stimulating factor
@nl
type
label
Mechanisms of immune suppressi ...... hage colony-stimulating factor
@ast
Mechanisms of immune suppressi ...... hage colony-stimulating factor
@en
Mechanisms of immune suppressi ...... hage colony-stimulating factor
@en-gb
Mechanisms of immune suppressi ...... hage colony-stimulating factor
@nl
prefLabel
Mechanisms of immune suppressi ...... hage colony-stimulating factor
@ast
Mechanisms of immune suppressi ...... hage colony-stimulating factor
@en
Mechanisms of immune suppressi ...... hage colony-stimulating factor
@en-gb
Mechanisms of immune suppressi ...... hage colony-stimulating factor
@nl
P2093
P921
P1476
Mechanisms of immune suppressi ...... hage colony-stimulating factor
@en
P2093
P304
P407
P577
1995-01-01T00:00:00Z